| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $33,353,505 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL177965 | Channelopathies of Inflammation | 000 | 2 | NIH | 2/14/2026 | $588,042 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MD017719 | Race and Medicare-Medicaid Dual Enrollment Disparities in Access to Quality and Intensity of Post-Acute Rehabilitation Care and Health Outcomes in Patients with Stroke | 001 | 5 | NIH | 2/23/2026 | $66,719 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MD017719 | Race and Medicare-Medicaid Dual Enrollment Disparities in Access to Quality and Intensity of Post-Acute Rehabilitation Care and Health Outcomes in Patients with Stroke | 000 | 5 | NIH | 1/2/2026 | $600,488 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD093826 | NETs: Protection or Harm in Neonatal Inflammation and Infection | 000 | 7 | NIH | 3/5/2026 | $507,761 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD099487 | Comorbid Disease in Women with Primary Ovarian Insufficiency | 000 | 7 | NIH | 1/16/2026 | $502,577 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 5 | NIH | 1/2/2026 | $887,934 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012252 | New algorithms and tools for large-scale genomic analyses | 000 | 5 | NIH | 1/21/2026 | $658,073 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES024681 | BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS | 000 | 15 | NIH | 1/13/2026 | $499,822 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032810 | A multicity study of wintertime inversions and acute cardiorespiratory health events in the western U.S. | 000 | 5 | NIH | 2/11/2026 | $453,256 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035158 | Regulation of Retinal Neurogenesis by Foxp1 | 000 | 3 | NIH | 12/4/2025 | $568,043 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035669 | Understanding and optimizing the influence of glaucoma drainage implant surface architecture and design to prevent post-operative fibrosis | 000 | 3 | NIH | 1/28/2026 | $358,559 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM146005 | Genome engineering in the nematode C. elegans | 000 | 4 | NIH | 1/27/2026 | $285,516 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK126903 | Validation and Identification of Genetic Variants in Peyronie's and Dupuytren's Disease that Predispose to Fibrosis and Inflammation | 000 | 5 | NIH | 12/17/2025 | $547,271 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK124333 | Immobilized ion receptors for maintaining electrolyte homeostasis with acellular wearable artificial kidneys | 002 | 7 | NIH | 2/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK124333 | Immobilized ion receptors for maintaining electrolyte homeostasis with acellular wearable artificial kidneys | 001 | 7 | NIH | 2/17/2026 | $573,410 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK128592 | Structures and Pharmacology of Cation-Chloride Cotransporters | 000 | 5 | NIH | 2/9/2026 | $680,627 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 000 | 4 | NIH | 2/24/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA289704 | Coordination of stress-adaptive cell states by CRIPTO in breast cancer heterogeneity and progression | 000 | 2 | NIH | 3/4/2026 | $435,802 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA289731 | The combined role of ARID1A loss and estrogen signaling in endometrial cancer | 000 | 3 | NIH | 2/27/2026 | $422,308 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DA061298 | Mechanisms of psychostimulant-sleep interactions | 000 | 2 | NIH | 2/19/2026 | $460,994 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA212415 | Transcriptional Regulation of Lung Cancer Identity | 000 | 9 | NIH | 12/18/2025 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA258386 | Telomere Dysfunction and Telomerase Reactivation in the Etiology and Progression of Liver Cancer | 002 | 6 | NIH | 3/5/2026 | $317,048 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259686 | A tissue viability imaging biomarker for use in non-invasive breast cancer therapy | 000 | 5 | NIH | 1/12/2026 | $540,619 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259182 | Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation | 000 | 5 | NIH | 2/26/2026 | $361,647 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA264971 | Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s | 000 | 5 | NIH | 1/28/2026 | $468,901 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 000 | 5 | NIH | 2/12/2026 | $323,658 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA131261 | Studying the initiation, progression and therapy of lung cancer in mouse models | 000 | 14 | NIH | 1/16/2026 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162943 | Microbial Ecology-Guided Discovery of Antibacterial Drugs | 000 | 5 | NIH | 1/8/2026 | $635,442 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162929 | Targeting OCA-B in multiple sclerosis | 000 | 5 | NIH | 1/21/2026 | $406,002 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI172210 | Biophysical parameters of self-reactive TCR engagement in T1D | 000 | 4 | NIH | 1/30/2026 | $666,153 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI175494 | Mechanisms of T cell persistence during chronic autoimmunity | 000 | 3 | NIH | 12/1/2025 | $668,683 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI173406 | Early life regulation of microbiota specific thymic T cell development | 000 | 4 | NIH | 12/5/2025 | $817,057 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI187812 | Deciphering the Interplay of Depleting Anti-PD-1 Antibodies and Autoimmune Environments in Type-1 Diabetes: Towards Better Utility of Therapeutic Antibody | 000 | 1 | NIH | 2/19/2026 | $756,078 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS137105 | Defining the contribution from endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice | 000 | 2 | NIH | 12/12/2025 | $231,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25CA287902 | Innovative approaches to randomized behavioral clinical trials | 000 | 3 | NIH | 2/26/2026 | $207,111 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25NS130964 | Intermountain Doctoral Education to Advance Students (IDEAS) in Neuroscience | 000 | 4 | NIH | 1/13/2026 | $237,922 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA289101 | Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma | 000 | 2 | NIH | 1/16/2026 | $189,616 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21EB035378 | A gaze-controlled neck exoskeleton for dropped head syndrome | 000 | 3 | NIH | 12/24/2025 | $146,829 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21EY037023 | Chimeric model for study of human retinal microglia in vivo | 000 | 2 | NIH | 1/29/2026 | $195,300 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R13HD079163 | PRS Young Investigators Grants Workshop | 000 | 13 | NIH | 1/22/2026 | $10,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG098603 | Cognitive-Motor Processes of Volitional Stepping | 000 | 1 | NIH | 2/9/2026 | $603,165 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI189586 | Development of HTS for discovery of IL-25 inhibitors | 000 | 1 | NIH | 2/6/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI196901 | Dissecting T Cell Developmental Defects in Down Syndrome | 000 | 1 | NIH | 1/30/2026 | $454,482 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI197490 | Cholesterol Metabolism in Regulatory T cell Function | 000 | 1 | NIH | 1/30/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS125359 | Regulation of NMDAR-Mediated Synaptic Signaling | 000 | 5 | NIH | 12/23/2025 | $475,617 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS126652 | Exploring p53-mediated ferroptosis to treat IDH1-mutant glioma | 000 | 4 | NIH | 3/4/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH128187 | The role of distributional reinforcement learning in human neurons during impulsive choices | 000 | 5 | NIH | 2/11/2026 | $447,773 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 4 | NIH | 2/11/2026 | $584,687 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 3 | NIH | 2/9/2026 | $616,643 |
|
